• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Sale!
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC])

$3,600.00 – $7,200.00

Clear
SKU: KLI15515800 Categories: Diagnostics Market Research, Immunoassays, Point-of-Care Diagnostics Pages: 157
  • Description
  • Table of Contents
  • Latest reports

Description

HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC])

Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including:

  • Global HIV Testing Market, 2015-2022 (in millions at manufacturer level)
  • Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC)
  • Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC)

The three categories of the global HIV testing market – lab-based immunoassay HIV testing, molecular HIV testing, and point-of-care (POC) HIV testing – are examined in the report as well, providing the following data points: size and growth of lab-based HIV testing revenues, 2017-2022; selected companies marketing central lab-based HIV immunoassays worldwide; size and growth of molecular HIV testing revenues, 2017-2022; market-available HIV molecular diagnostic platforms; size and growth of POC HIV testing revenues, 2017-2022; size and growth of professional POC HIV testing revenues, 2017-2022; size and growth of self-testing HIV testing revenues, 2017-2022; and selected rapid HIV professional and home tests.

The report features analysis by geographic region, including the United States, Europe (with country level market information), Japan, and the rest of world. Revenue information provided includes: size and growth for United States HIV testing revenues, 2017-2022; size and growth for Europe HIV testing revenues, 2017-2022; European regional market revenue share by country, 2017 (%; Germany, France, UK, Italy, Spain, Turkey, Other); size and growth for Japan HIV testing revenues, 2017-2022; size and growth for rest of world HIV testing revenues, 2017-2022; and ROW regional market revenue share by country, 2017 (%; China, India, Brazil, Russia, Canada, SE Asia, ROW).

Competition in the HIV testing market is intense and it is expected to increase as more innovative HIV tests enter the marketplace. The report features a full competitive analysis of the market. Abbott, Danaher (Beckman Coulter and Cepheid), Roche, and Siemens Healthineers are among the market leaders in HIV testing profiled in the report.

Table of Contents

  1. EXECUTIVE SUMMARY

OVERVIEW

SCOPE AND METHODOLOGY

SIZE AND GROWTH OF THE MARKET

Table 1-1: Global HIV Testing Market 2015-2022 (in millions $ at manufacturer level)

COMPETITIVE ANALYSIS

  1. INTRODUCTION

EPIDEMIOLOGY

History

Types of HIV

Transmission

ETIOLOGY

HIV Structure

HIV Binding and Infection

PATHOGENESIS

HIV Effect on Immune Cells at the Cellular Level

Viral Production and Cell Death

Progression of HIV Infection

CDC HIV Classification

HIV Statistics Worldwide

Figure 2-1: Worldwide Individuals Living with HIV, by Geographic Region, 2016 (in millions) (Africa, Americas, SE Asia, Europe, West Pacific)

Table 2-1: Global HIV Statistics by Selected Countries 2016 (Angola, Botswana, Brazil, Cambodia, Cameroon, China, Republic of Congo, France, India, Italy, Kenya, Namibia, Nigeria, Spain, South Africa, United States, Vietnam, Zimbabwe)

HIV DIAGNOSTIC TESTING DIFFICULTIES

LACK OF PROFESSIONAL TRAINING

HIV AND CANCER

Table 2-2: Current Research Trials (Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies) for HIV and Cancer Synergy as of October 1, 2017 (Lymphoma, Kaposi Sarcoma, Anal Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Liver Cancer, Others, Total)

  1. HIV TESTING

CATEGORIES OF HIV TESTS

Lab-based Immunoassay

Molecular

Point-of-Care (Rapid)

TYPES OF HIV TESTING

Antibody Tests

Table 3-1: Selected EIA HIV Assays

Table 3-2: Selected Western Blot HIV Assays

Table 3-3: Selected Indirect Fluorescent Antibody HIV Assays

Line Immunoassay

Combination Tests

Table 3-4: Selected Combination HIV Assays

Nucleic Acid Tests

Table 3-5: Selected Nucleic Acid HIV Assays

Table 3-6: Selected HIV Assays Used for Screening

TYPES OF HIV TESTING SAMPLES

Blood Tests

Oral Fluid Test

Urine-based HIV Tests

  1. MARKET SIZE AND GROWTH AND COMPETITIVE ANALYSIS

GLOBAL HIV TESTING MARKET

Table 4-1: Global HIV Testing Market 2015-2022 (in millions at manufacturer level)

Figure 4-1: Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC)

Figure 4-2: Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC)

ANALYSIS BY HIV TEST CATEGORY

Lab-based Immunoassay HIV Testing Market

Table 4-2: Market Size and Growth for Lab-based HIV Testing Market, 2017-2022 ($millions)

Table 4-3: Selected Companies Marketing Central Lab-Based HIV

Immunoassays Worldwide

Molecular HIV Testing Market

Table 4-4: Market Size and Growth for Molecular HIV Testing Market, 2017-2022 ($millions)

Table 4-5: Market-Available HIV Molecular Diagnostic Platforms

Point-of-Care (Rapid) HIV Testing Market

Table 4-6: Market Size and Growth for POC HIV Testing Market, 2017-2022 ($millions)

Table 4-7: Market Size and Growth for Professional POC HIV Testing Market, 2017-2022 ($millions)

Table 4-8: Market Size and Growth for Self-Testing HIV Testing Market, 2017-2022 ($millions)

Table 4-9: Selected Rapid HIV Professional and Home Tests

Analysis by Geographic Region

Table 4-10: Market Size and Growth for United States HIV Testing Market, 2017-2022 ($millions)

Table 4-11: Market Size and Growth for Europe HIV Testing Market, 2017-2022 ($millions)

Figure 4-3: European Regional Market Share by Country, % 2017 (Germany, France, UK, Italy, Spain, Turkey, Other)

Table 4-12: Market Size and Growth for Japan HIV Testing Market, 2017-2022 ($millions)

Table 4-13: Market Size and Growth for Rest of World HIV Testing Market, 2017-2022 ($millions)

Figure 4-4: ROW Regional Market Share by Country, % 2017 (China, India, Brazil, Russia, Canada, SE Asia, ROW)

COMPETITIVE ANALYSIS

Table 4-14: Global HIV Testing Market Analysis by Competitor Revenues and Market Share % 2017

Figure 4-5: Global HIV Testing Market Analysis by Competitor Market Share %, 2017

MARKET CONCLUSIONS

  1. COMPANY PROFILES

ABBOTT LABORATORIES

Table-5-1: Abbott Corporate Summary

Company Overview

Product

Company Financials

Table 5-2: Abbott Laboratories Revenue (2014-2017) ($ millions)

ACCUBIOTECH CO, LTD.

Table 5-3: AccuBioTech Summary

Company Overview

Products

AKERS BIOSCIENCES, INC.

Table 5-6: Akers Biosciences Corporate Summary

Company Overview

Products

Company Financials

Table 5-7: Akers Biosciences (2014-2017) ($ thousands)

ALERE INC

Table 5-4: Alere Corporate Summary

Company Overview

Product

Company Financials

Table 5-5: Alere Revenue (2014-2017) ($ millions)

ARKRAY, INC

Table 5-8: ARKRAY Corporate Summary

Company Overview

Products

ARTRON LABORATORIES INC.

Table 5-9: Artron Laboratories Corporate Summary

Company Overview

Products

ATLAS LINK BIOTECH CO., LTD

Table 5-10: Atlas Link Biotech Summary

Company Overview

Products

AUTOBIO DIAGNOSTICS CO., LTD

Table 5-11: Autobio Diagnostics Summary

Company Overview

Products

AVIOQ, INC.

Table 5-12: Avioq Corporate Summary

Company Overview

Products

BECKMAN COULTER, INC

Table 5-13: Beckman Coulter Corporate Summary

Company Overview

Products

Company Financials

Table 5-14: Beckman Coulter (part of Danaher) (2014-2017) ($ millions)

BECTON DICKINSON

Table 5-15: Becton Dickinson Corporate Summary

Company Overview

Products

Company Financials

Table 5-16: Becton Dickinson (2014-2017) ($ millions)

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.

Table 5-17: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary

Company Overview

Products

BHAT BIO-TECH INDIA PRIVATE LTD. (BBI)

Table 5-18: Bhat Bio-Tech India Private Corporate Summary

Company Overview

Products

BIOKIT S.A.

Table 5-19: Biokit Corporate Summary

Company Overview

Products

BIOLYTICAL LABORATORIES

Table 5-20: bioLytical Laboratories Summary

Company Overview

Products

BIOMERIEUX SA

Table 5-21: bioMerieux SA Corporate Summary

Company Overview

Products

Company Financials

Table 5-22: bioMerieux Revenues (2014-2017) ($ millions)

BIO-RAD LABORATORIES INC

Table 5-23: Bio-Rad Labs Corporate Summary

Company Overview

Products

Company Financials

Table 5-24: Bio-Rad Labs (2014-2017) ($ millions)

CALYPTE BIOMEDICAL CORPORATION

Table 5-25: Calypte Biomedical Summary

Company Overview

Products

CAVIDI

Table 5-26: Cavidi Corporate Summary

Company Overview

Products

CEPHEID

Table 5-27: Cepheid Corporate Summary

Company Overview

Products

Company Financials

Table 5-28: Cepheid Revenues (2014-2017) ($ millions)

CHEMBIO DIAGNOSTIC SYSTEMS, INC.

Table 5-29: Chembio Diagnostic Corporate Summary

Company Overview

Products

Company Financials

Table 5-30: Chembio Diagnostics Revenues (2014-2017) ($ millions)

CTK BIOTECH, INC.

Table 5-31: CTK Biotech Corporate Summary

Company Overview

Products

DANAHER CORPORATION

Table 5-32: Danaher Summary

Company Overview

Products

Company Financials

Table 5-33: Danaher Revenues (2014-2017) ($ millions)

DIAGNOSTICS FOR THE REAL WORLD LTD

Table 5-35: Diagnostics for the Real World Summary

Company Overview

Products

DIALAB GMBH

Table 5-34: DIALAB Summary

Company Overview

Products

ERBA MOLECULAR

Table 5-36: ERBA Molecular Summary

Company Overview

Products

EY LABORATORIES

Table 5-37: EY Laboratories Summary

Company Overview

Products

GLYSBY SNC

Table 5-38: GlysBy Corporate Summary

Company Overview

Products

GRIFOLS INTERNATIONAL S.A.

Table 5-39: Grifols International S.A. Corporate Summary

Company Overview

Products

Company Financials

Table 5-40: Grifols (2014-2017) ($ millions)

HEMA DIAGNOSTIC SYSTEMS, LLC

Table 5-41: Hema Diagnostics Systems Corporate Summary

Company Overview

Products

HOLOGIC, INC.

Table 5-42: Hologic Corporate Summary

Company Overview

Products

Company Financials

Table 5-43: Hologic (2014-2017) ($ millions)

MBIO DIAGNOSTICS, INC

Table 5-44: Mbio Diagnostics Summary

Company Overview

Products

MEDMIRA, INC

Table 5-45: MedMira Corporate Summary

Company Overview

Products

Company Financials

Table 5-46: MedMira (2014-2017) ($ millions)

MOLBIO DIAGNOSTICS PVT. LTD

Table 5-47: Molbio Diagnostics Corporate Summary

Company Overview

Products

NANOBIOSYM, INC

Table 5-48: Nanobiosym Corporate Summary

Company Overview

Products

NORTHWESTERN GLOBAL HEALTH FOUNDATION (NWGHF)

Table 5-49: Northwestern Global Health Foundation Summary

Company Overview

Products

OMEGA DIAGNOSTICS GROUP PLC

Table 5-50: Omega Diagnostics Corporate Summary

Company Overview

Products

ORASURE TECHNOLOGIES, INC.

Table 5-51: OraSure Technologies Corporate Summary

Company Overview

Products

Company Financials

Table 5-52: OraSure Revenue (2014-2017) ($ millions)

ORTHO CLINICAL DIAGNOSTICS

Table 5-53: Ortho Clinical Diagnostics Corporate Summary

Company Overview

Products

Company Financials

Table 5-54: Ortho Clinical Diagnostics Revenue (2014-2017) ($ millions)

PRINCETON BIOMEDITECH CORPORATION

Table 5-55: Princeton Biomeditech Corporate Summary

Company Overview

Products

QUIDEL CORPORATION

Table 5-56: Quidel Corporate Summary

Company Overview

Products

Company Financials

Table 5-57: Quidel Revenue (2014-2017) ($ millions)

ROCHE DIAGNOSTIC CORPORATION

Table 5-58: Roche Corporate Summary

Company Overview

Products

Company Financials

Table 5-59: Roche Revenue (2014-2017) ($ millions)

SACACE BIOTECHNOLOGIES S.R.L.

Table 5-60: Sacace Corporate Summary

Company Overview

Products

SAVYON DIAGNOSTICS LTD.

Table 5-61: Savyon Diagnostics Summary

Company Overview

Products

SIEMENS HEALTHINEERS

Table 5-62: Siemens Healthineers Corporate Summary

Company Overview

Products

Company Financials

Table 5-63: Siemens Healthineers Revenue (2014-2017) ($ millions)

STANDARD DIAGNOSTICS, INC.

Table 5-64: Standard Diagnostics Corporate Summary

Company Overview

Products

TRINITY BIOTECH PLC

Table 5-65: Trinity Biotech Corporate Summary

Company Overview

Products

Company Financials

Table 5-66: Trinity Biotech Revenue (2014-2017) ($ thousands)

WAMA DIAGNOSTICA

Table 5-67: WAMA Diagnostica Corporate Summary

Company Overview

Products

WAVE 80 BIOSCIENCES

Table 5-68: Wave 80 Biosciences Corporate Summary

Company Overview

Products

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00
  • Placeholder image

    Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Selected New Products in IVDCancer Liquid Biopsy Market Assessment
Scroll to top